Ferozsons Laboratories Statistics

Total Valuation

Ferozsons Laboratories has a market cap or net worth of PKR 12.46 billion. The enterprise value is 16.92 billion.

Market Cap	12.46B
Enterprise Value	16.92B

Important Dates

The next estimated earnings date is Tuesday, October 15, 2024.

Earnings Date	Oct 15, 2024
Ex-Dividend Date	Oct 18, 2024

Share Statistics

Ferozsons Laboratories has 43.47 million shares outstanding.

Shares Outstanding	43.47M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	8.43%
Float	26.98M

Valuation Ratios

The trailing PE ratio is 18.23.

PE Ratio	18.23
Forward PE	n/a
PS Ratio	0.79
PB Ratio	1.11
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.04, with an EV/FCF ratio of -14.59.

EV / Earnings	24.77
EV / Sales	1.07
EV / EBITDA	8.04
EV / EBIT	10.65
EV / FCF	-14.59

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.42.

Current Ratio	1.61
Quick Ratio	0.62
Debt / Equity	0.42
Debt / EBITDA	2.34
Debt / FCF	-4.24
Interest Coverage	2.45

Financial Efficiency

Return on equity (ROE) is 7.49% and return on invested capital (ROIC) is 6.95%.

Return on Equity (ROE)	7.49%
Return on Assets (ROA)	5.18%
Return on Capital (ROIC)	6.95%
Revenue Per Employee	8.36M
Profits Per Employee	360,309
Employee Count	1,680
Asset Turnover	0.83
Inventory Turnover	1.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +84.52% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+84.52%
50-Day Moving Average	284.19
200-Day Moving Average	244.37
Relative Strength Index (RSI)	46.96
Average Volume (20 Days)	392,760

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ferozsons Laboratories had revenue of PKR 15.85 billion and earned 683.15 million in profits. Earnings per share was 15.72.

Revenue	15.85B
Gross Profit	6.44B
Operating Income	1.59B
Pretax Income	1.14B
Net Income	683.15M
EBITDA	2.11B
EBIT	1.59B
Earnings Per Share (EPS)	15.72

Full Income Statement

Balance Sheet

The company has 1.05 billion in cash and 4.92 billion in debt, giving a net cash position of -3.87 billion or -89.08 per share.

Cash & Cash Equivalents	1.05B
Total Debt	4.92B
Net Cash	-3.87B
Net Cash Per Share	-89.08
Equity (Book Value)	11.82B
Book Value Per Share	258.31
Working Capital	3.70B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -615.84 million and capital expenditures -544.04 million, giving a free cash flow of -1.16 billion.

Operating Cash Flow	-615.84M
Capital Expenditures	-544.04M
Free Cash Flow	-1.16B
FCF Per Share	-26.68

Full Cash Flow Statement

Margins

Gross margin is 40.60%, with operating and profit margins of 10.02% and 4.31%.

Gross Margin	40.60%
Operating Margin	10.02%
Pretax Margin	7.19%
Profit Margin	4.31%
EBITDA Margin	13.28%
EBIT Margin	10.02%
FCF Margin	-7.32%

Dividends & Yields

This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 1.05%.

Dividend Per Share	3.00
Dividend Yield	1.05%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	0.12%
Buyback Yield	n/a
Shareholder Yield	1.05%
Earnings Yield	5.48%
FCF Yield	-9.31%

Dividend Details

Stock Splits

The last stock split was on September 21, 2022. It was a forward split with a ratio of 1.2.

Last Split Date	Sep 21, 2022
Split Type	Forward
Split Ratio	1.2

Scores

Ferozsons Laboratories has an Altman Z-Score of 2.16. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.16
Piotroski F-Score	n/a